Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jan;60(1):e27401.
doi: 10.1002/ppul.27401. Epub 2024 Dec 3.

European Respiratory Society Research Seminar on Preventing Pediatric Asthma

Affiliations
Review

European Respiratory Society Research Seminar on Preventing Pediatric Asthma

Jonathan Grigg et al. Pediatr Pulmonol. 2025 Jan.

Abstract

This report is a summary of the presentations given at the European Respiratory Society's Research Seminar on Asthma Prevention. The seminar reviewed both epidemiological and mechanistic studies and concluded that; (i) reducing exposure of pregnant women and children to air pollution will reduce incident asthma, (ii) there are promising data that both fish oil and a component of raw cow's milk prevent asthma, and (iii) modulating trained immunity by either mimicking helminth infection or oral and sublingual bacterial products is a promising area of research.

Keywords: asthma; children; prevention.

PubMed Disclaimer

Conflict of interest statement

The research seminar was supported by a grant from the European Respiratory Society. J.G. Support; NIHR Senior Investigator Award, Grants; OM Pharma, Marinomed; Advisory board; OM Pharma, Omron, Honoraria; AstraZeneca, Equipment and materials donation; OM Pharma, Immunotek S.L., Omron, Payment for medical evidence; Hogg Robertson Solicitors. K.B. Honoraria; Sanofi and AstraZeneca, Meeting support; ALK‐Abelló Nordic, Advisory Board; ALK‐Abelló Nordic. A.C. Grants: Medical Research Council, EPSRC, Wellcome Trust, Consulting fees; Sanofi, Reacta Biotech, Honoraria; GSK AstraZeneca, Sanofi, Stallergens‐Greer, La Roche Possay, Board Member; World Allergy Organization. M.E. Grants; German Federal Ministry of Education and Research, Dutch Longfonds, Bavarian State Ministry of Health and Care, Patents; EP000002361632B1, EP1964570B1, Equipment donation; Royal Friesland Campina. M.S. Grants; Swiss National Science Foundation (SNSF) nr 189334/1 and 224154, GSK, Novartis, Stiftung vorm. Bündner Heilstätte Arosa and OM Pharma; Speaker's fee; AstraZeneca. Board Member; EAACI. C.P. Support; Employee of OM Pharma, Patents; US20220143111A1, WO2020182970A, Shares; OM Pharma. P.O. Grants; UCM‐Inmunotek S.L, Comunidad Autónoma de Madrid (CAM), MICINNIN, Consulting fees; AstraZeneca, Pfizer, GlaxoSmithKline, Inmunotek S.L, Novartis, Sanofi‐Genzyme, Honoraria; AstraZeneca, Pfizer, GlaxoSmithKline, Inmunotek S.L, Novartis, Sanofi‐Genzyme, Advisory Board; AstraZeneca, Pfizer, GlaxoSmithKline, Inmunotek S.L, Novartis, Sanofi‐Genzyme, Board Member; EAACI. D.V Grants; National Institute of Health. E.v.M. Grants; German Research Foundation (DFG), German Federal Ministry of Education and Research (BMBF), German Center for Lung Research, Bavarian State Ministry of Health and Care, OM Pharma S.A, BMBF (Federal Ministry of Education and Research), European Research Council, Royalties/licences; Elsevier GmbH, Georg Thieme Verlag, Springer‐Verlag GmbH, Elsevier Ltd, Springer Nature Group, Deutscher Apotheker Verlag, Honoraria; ALK‐Abello Arzneimittel GmbH, Japanese Society of Pediatric Allergy and Clinical Immunology (JSPACI), Klinikum Rechts der Isar, University of Colorado, Paul‐Martini‐Stiftung, Astra Zeneca BioPharmaceuticals Medical, Imperial College London, Children's Hospital Research Institute of Manitoba Kompetenzzentrum für Ernährung (Kern), OM Pharma S.A. Swedish Pediatric Society for Allergy and Lung Medicine, Chinese College of Allergy and Asthma (CCAA), Abbott Laboratories, Deutscher Apotheker Verlag GmbH & Co. KG, Socieded Chilena de Enfermedades Respiratorias, Japanese Society of Allergology, British Society for Asthma and Clinical Immunology, American Academy of Allergy, Asthma & Immunology, European Respiratory Society. The remaining authors declare no conflicts of interest.

References

    1. Beasley R., Semprini A., and Mitchell E. A., “Risk Factors for Asthma: Is Prevention Possible?,” Lancet 386, no. 9998 (2015): 1075–1085. - PubMed
    1. Van Wonderen K. E., Van Der Mark L. B., Mohrs J., Bindels P. J. E., Van Aalderen W. M. C., and Ter Riet G., “Different Definitions in Childhood Asthma: How Dependable Is the Dependent Variable?,” European Respiratory Journal 36, no. 1 (2010): 48–56. - PubMed
    1. Lederer D. J., Bell S. C., Branson R. D., et al., “Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals,” Annals of the American Thoracic Society 16, no. 1 (2019): 22–28. - PubMed
    1. Shaheen S. O., Newson R. B., Smith G. D., and Henderson A. J., “Prenatal Paracetamol Exposure and Asthma: Further Evidence Against Confounding,” International Journal of Epidemiology 39, no. 3 (2010): 790–794. - PubMed
    1. Richmond R. C., Al‐Amin A., Davey Smith G., and Relton C. L., “Approaches for Drawing Causal Inferences From Epidemiological Birth Cohorts: A Review,” Early Human Development 90, no. 11 (2014): 769–780. - PMC - PubMed